The influence of formulation on the dissolution profile of diclofenac sodium tablets

Drug Development and Industrial Pharmacy

Volumn 32, Issue 9, 2006, Pages 1103-1109

  De Castro, W V ^a,c   Pires, M A S ^a   Oliveira, M A ^a   Vianna Soares, C D ^b   Nunan, E A ^b   Pianetti, G A ^b   Moreira Campos, L M ^b   Mertens Talcott, S U ^c   Derendorf, H ^c  

^a FUNDAÇÃO EZEQUIEL DIAS   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF FLORIDA HEALTH   (United States)

Author keywords

Croscarmellose sodium; Diclofenac sodium; Dissolution profile; Eudragit L 100

Indexed keywords

2 PROPANOL; CROSCARMELLOSE SODIUM; DICLOFENAC; DISINTEGRATING AGENT; DODECYL SULFATE SODIUM; EUDRAGIT; MACROGOL 6000; MAGNESIUM STEARATE; MANNITOL; MICROCRYSTALLINE CELLULOSE; PHTHALIC ACID DIBUTYL ESTER; PIGMENT; STARCH; TALC; TITANIUM DIOXIDE;

ARTICLE; COMPARATIVE STUDY; DELAYED RELEASE FORMULATION; DRUG DOSAGE FORM; DRUG SOLUBILITY; EVALUATION; FILM COATING; TABLET; TABLET MANUFACTURE; THICKNESS;

ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CARBOXYMETHYLCELLULOSE; CARBOXYMETHYLCELLULOSE SODIUM; CHEMISTRY, PHARMACEUTICAL; DELAYED-ACTION PREPARATIONS; DICLOFENAC; EXCIPIENTS; POLYMETHACRYLIC ACIDS; SOLUBILITY; TABLETS;

EID: 33749483682     PISSN: 03639045     EISSN: 15205762     Source Type: Journal    
DOI: 10.1080/03639040600815152     Document Type: Article

References (36)

1. Anderson, N. H., Bauer, M., Boussac, N., Khan-Malek, R., Munden, P., & Sardaro, M. (1998). An evaluation of fit factors and dissolution efficiency for the comparison of in vitro dissolution profiles. J. Pharm. Biomed. Anal., 17(4-5), 811-822.
2. Andrade, C. M. B., Mylius, L. C., Silva, N. M., Steppe, M., Schuck, V. J. A., Shapoval, E. S., & Dalla Costa, T. (2002). Evaluation of the dissolution efficiency and similarity factor f2 for the comparison of dissolution profiles in vitro. Rev. Bras. Farm., 83(1-4), 19-26.
3. Blanchard, J. (1978). Formulations factors affecting drug bioavailability. Am. J. Pharm., 150, 132-151.
4. Bolhuis, G. K., van Kamp, H. V., Lerk, C. F., & Sessink, F. G. M. (1982). On the mechanism of action of modern disintegrants. Acta Pharm. Technol., 28, 111-114.
5. Brossard, C., & Wouessidjewe, D. (1990). Contrôle de dissolution de formes pharmaceutiques orales solides à libération ralentie. STP Pharma., 6(10), 728-741.
6. Chow, S. C., & Ki, F. Y. (1997). Statistical comparison between dissolution profiles of drug products. J. Biopharm. Stat., 7(2), 241-258.
7. Corrigan, O. I., Devlin, Y., & Butler, J. (2003). Influence of dissolution medium buffer composition on ketoprofen release from ER products and in vitro-in vivo correlation. Int. J. Pharm., 254(2), 147-154.
8. Farmacopéia Brasileira. (2003). 4th Edition. (p. 144.1). Atheneu: São Paulo.
9. Ferraz, H. G., Pinho, J. J. R. G., Ferreira, A. M., Ikedo, M. T., & Pereira, R. R. (1998). Estudo comparativo do perfil de dissolucao de comprimidos e drágeas contendo diclofenaco potássico disponíveis no mercado brasileiro. Rev. Bras. Farm., 79(1-2), 15-16.
10. Flynn, G., Yalkowsky, S. H., & Roseman, T. J. (1974). Mass transport phenomenon and models: theoretical concepts. J. Pharm. Sci., 63, 479-510.
11. Giunchedi, P., Conte, U., & La Manna, A. (1990). A swellable polymer as carbamazepine dissolution rate enhancer. Boll. Chim. Farm., 9(1), 17-20.
12. Gohel, C. M., & Panchal, K. M. (2000). Comparison of in vitro dissolution profiles. Pharm. Tech., 24(3), 92-103.
13. Gozáles, M., Retaco, M., Pizzorno, M. T., & Volonté, M. G. (1995). Manufacturing technology on the dissolution of ampicillin tablets. Boll. Chim. Farm., 134(8), 448-453.
14. Ho, H., Liu, C., Lin, H., & Sheu, M. (1997). The development of matrix tablets for diclofenac sodium based on an empirical in vitro and in vivo correlation. J. Control. Release, 49(2-3), 149-156.
15. Holgado, M. A., Carabalo, I., Alvarez-Fuentes, J., Fernández- Hervás, M. J., Fernández-Avérado, M., & Rabasco, A. M. (1995). Influence of the diluents and manufacturing methods on the in vitro dissolution of carteolol hydrochloride matrix tablets. Int. J. Pharm., 118, 151-160.
16. Johnson, J. R., Wang, L., Gordon, M. S., & Chowhan, T. Z. (1991). Effect of formulation solubility and hygroscopicity on disintegrating efficiency in tablets prepared by wet granulation, in terms of dissolution. J. Pharm. Sci., 80(5), 469-471.
17. Khalil, E., & Sallam, A. (1999). Interaction of two diclofenac acid salts with copolymers of ammoniomethacrylate: effect of additives and release profiles. Drug Dev. Ind. Pharm., 25(4), 419-427.
18. Khan, K. A. (1975). The concept of dissolution efficiency. J. Pharm. Pharmacol., 27, 48-49.
19. Ledwidge, M. T., & Corrigan, O. I. (1998). Effects of surface active characteristics and solid state forms on the pH solubility profiles of drug-salt systems. Int. J. Pharm., 174(1-2), 187-200.
20. Liu, C. H., Kao, Y. H., Chen, S. C., Sokoloski, T. D., & Sheu, M. T. (1995). In vitro and in vivo studies of diclofenac sodium controlledrelease matrix tablets. J. Pharm. Pharmacol., 47, 360-364.
21. Lorenzo-Lamoza, M. L., Remuñán-López, J. L., Vila-Jato, M. J., & Alonso, M. (1998). Design of microencapsulated chitosan micropheres for colonic drug delivery. J. Control. Release, 52, 109-118.
22. Moore, J. W., & Flanner, H. H. (1996). Mathematical comparison of dissolution profiles. Pharm. Tech., 20(6), 64-74.
23. O'Hara, T., Dunne, A., Butler, J., & Devane, J. (1998). A review of methods used to compare dissolution profile data. Pharm. Sci. Tech. Today, 1(5), 214-223.
24. Pinho, J. J. R. G., & Storpitis, S. (1999). Desenvolvimento e avaliação biofarmacêutica de comprimidos de liberação controlada de cloridrato de metformina empregando meio de dissolução com variação gradual de pH. Braz. J. Pharm. Sci., 35(1), 101-109.
25. Polli, J. E., Rekhi, G. S., Augsburger, L. L., & Shah, V. P. (1997). Methods to compare dissolution profiles and a rationale for wide dissolution specifications for metoprolol tartrate tablets. J. Pharm. Sci., 86, 690-700.
26. Prista, L. N., Alvez, A. C., & Morgado, R. (1996). Tecnologia farmacêutica. 4th Edition. (Vol. 3, 2257 pp.). Fundação Calouste Gulbenkian: Lisboa.
27. Sallmann, A. R. (1986). The history of diclofenac. Am. J. Med., 80(Suppl 4B), 29-33.
28. Shah, V. P., Tsong, Y., Sathe, P., & Liu, J. (1998). In vitro dissolution profile comparison-statistics and analysis of the similarity factor, f2. Pharm. Res., 15(6), 889-896.
29. Sheu, M., Chou, H., Kao, C., Liu, C., & Sokoloski, T. D. (1992). Dissolution of diclofenac sodium from matrix tablets. Int. J. Pharm., 85(1-3), 57-63.
30. Sielpmann, J., Lecomte, F., & Bodmeier, R. (1999). Diffusion-controlled drug delivery systems: calculation of the required composition to achieve desired release profiles. J. Control. Release, 60, 379-389.
31. Silverstein, R., & Bassler, G. C. (1967). Spectrometric Identification of Organic Compounds. 2nd Edition. (pp. 64-109). John Wiley and Sons: New York.
32. Sunada, H., Hasegawa, M., Makino, T., Sakamoto, H., Fujita, K., Tanino, T., Kokubo, H., & Kawaguchi, T. (1998). Study of standard tablet formulation based on fluidized-bed granulation. Drug Dev. Ind. Pharm., 24(3), 225-233.
33. U. S. Department of Health and Human Services. (1997). Guidance for Industry: Modified Release Solid Oral Dosage Forms: Scale-Up and Post Approval Changes (SUPAC-MR): Chemistry, Manufacturing and Controls. In Vivo Dissolution Test and In Vitro Bioequivalence Documentation. Rockville, MD: Center for Drug Evaluation and Research (CDER). Available at: http://www. fda.gov/cder/guidance/ 1214fnl.pdf. (Retrieved October, 1st, 2005).
34. Vaughan, D. P., & Tucker, G. T. (1976). An analysis of the applications of dissolution effeciency. J. Pharm. Pharmacol., 28, 932-933.
35. Villanova, J. C. O., Brandão, M. A. F., Reis, J. E. P., Macedo, A. B. J., & Pinho, J. J. R. G. (1999). Estudo comparativo de formas farmacêuticas sólidas contendo dipirona comercializadas no mercado nacional. Braz. J. Pharm. Sci., 35(1), 87-93.
36. Zuleger, S., & Lippold, B. C. (2001). Polymer particle erosion controlling drug release. I. Factors influencing drug release and characterization of the release mechanism. Int. J. Pharm., 217(1-2), 139-152.